Gain insight into how principal investigator scarcity, frequent protocol amendments, and uneven site performance undermine enrollment and extend timelines.
Matt Holms
Advertisement
Vice President of Sales, Citeline
Articles by Matt Holms
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
4
Streamlining Clinical Data to Reduce Site and Participant Burden
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
